Vitamin D Deficiency in Human Immunodeficiency Virus

The effect of Cholecalciferol and dietary advice on Vitamin D levels in participants with Human Immunodeficiency Virus Infection

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12611000631909

Enrollment

Registered

2011-06-21

Start date

2009-07-02

Completion date

2010-06-23

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary purpose of the study is to measure the prevalence of vitamin D deficiency in the HIV population at the Alfred Hospital, and then to evaluate the effectiveness of vitamin D supplementation in this population.

Interventions

Supplementation with 5000 IU Cholecalciferol orally, daily for 12 months, in addition to a single 30 minute interview with dietitian at baseline with provision of dietary advice regarding sources of vitamin D in diet plus advice regarding safe levels of sunlight exposure

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Documented HIV infection Age greater than 18 years Vitamin D deficiency (<50 nmol/l)

Exclusion criteria

Pregnancy On vitamin D supplementation

Outcome results